Humanwell Healthcare (Group) Co (SHSE:600079) Total Stockholders Equity: ¥19,309 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600079 Humanwell Healthcare (Group) Co Ltd SHSE:600079
60 GF Score
Price ¥18.73
GF Value ¥20.88
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Humanwell Healthcare (Group) Co Total Stockholders Equity?

Humanwell Healthcare (Group) Co SHSE:600079 -0.85% 60 Total Stockholders Equity is ¥19,309 Mil as of Jun. 2026. GuruFocus rates SHSE:600079 with a GF Score™ of 60/100 and a GF Value™ of ¥20.88 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Humanwell Healthcare (Group) Co's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ¥19,309 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Humanwell Healthcare (Group) Co's Book Value per Share for the quarter that ended in Jun. 2026 was ¥11.83. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Humanwell Healthcare (Group) Co's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.43.

Humanwell Healthcare (Group) Co  (SHSE:600079) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Humanwell Healthcare (Group) Co's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(19308.988-0)/1632.226
=11.83

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Humanwell Healthcare (Group) Co's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(5458.489 + 2757.199) / 19308.988
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humanwell Healthcare (Group) Co Total Stockholders Equity Related Terms

Humanwell Healthcare (Group) Co Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Humanwell Healthcare (Group) Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humanwell Healthcare (Group) Co Total Stockholders Equity Chart

Humanwell Healthcare (Group) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,948.25 15,036.99 17,043.60 17,623.82 18,913.31

Humanwell Healthcare (Group) Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18,335.05 18,913.74 18,913.31 19,417.09 19,308.99
SHSE:600079
60GF Score
Humanwell Healthcare (Group) Co Ltd SHSE:600079
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of ¥19,309 Mil mean?
Humanwell Healthcare (Group) Co (SHSE:600079) has a Total Stockholders Equity of ¥19,309 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Humanwell Healthcare (Group) Co and its competitors.
Is Humanwell Healthcare (Group) Co's Total Stockholders Equity too high?
Humanwell Healthcare (Group) Co's current Total Stockholders Equity is ¥19,309 Mil. Overall, Humanwell Healthcare (Group) Co has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Humanwell Healthcare (Group) Co's Total Stockholders Equity compare to ZTS?
Humanwell Healthcare (Group) Co's Total Stockholders Equity of ¥19,309 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Humanwell Healthcare (Group) Co and its competitors. Humanwell Healthcare (Group) Co's current Total Stockholders Equity is ¥19,309 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humanwell Healthcare (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co (SHSE:600079) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.88, compared to a current price of ¥18.73 — trading 10.3% below its estimated fair value. The current Total Stockholders Equity is ¥19,309 Mil. Humanwell Healthcare (Group) Co's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Humanwell Healthcare (Group) Co (SHSE:600079), the current Total Stockholders Equity is ¥19,309 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Humanwell Healthcare (Group) Co (SHSE:600079) Overvalued in 2026?

Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co stock appears to be undervalued. The current stock price of ¥18.73 is trading 10.3% below its estimated GF Value™ of ¥20.88. GuruFocus considers Humanwell Healthcare (Group) Co to be Modestly Undervalued.

Key valuation signals for SHSE:600079:

  • Total Stockholders Equity: ¥19,309 Mil
  • GF Value™: ¥20.88 vs. price of ¥18.73 (10.3% below fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Humanwell Healthcare (Group) Co Business Description

Address No. 666, Gaoxin Avenue, East Lake High-tech Development Zone, Hubei Province, Wuhan, CHN, 430075
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. It provides medicinal products including fertility-regulating drugs, Uyghur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
60GF Score

Get the complete analysis for SHSE:600079

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.73
Price
¥20.88
GF Value